Lupin Q1 net profit up 49 pc to Rs 303.05
The company had posted a net profit of Rs 202.76 crore in the year-ago period
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
7th Annual International Conference Disso India to be held in Chandigarh
To be held on 12th and 13th September, 2019, the conference will promote introduction of new technology and will have…
PURIFY 2019 to be held in December
The Chromatography Purification Conclave to, be held at The Westin Hyderabad Mindspace would touch upon varied aspects of…
Meril Life Sciences becomes India’s first to receive CE marking for 100 micron Bioresorbable…
MeRes100 BRS has shown long-term positive safety and sustained efficacy outcomes for patients with coronary artery disease and…
Roche says Tecentriq prevents disease worsening or death in patients with advanced bladder cancer
Roche is evaluating treatment in combination with other medicines for early, advanced forms of disease
Sanofi and Regeneron get EU approval for Dupixent
European Commission has extended marketing authorisation for Dupixent European Union to include adolescents 12 to 17 years of age…
Granules India receives US FDA approval for Amphetamine Sulfate tablets
The product is generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength
Lupin’s Mandideep facility inspection completed by ANSM
The inspection closed with no critical or major observations
Natco Pharma receives EIR from US FDA
The EIR was issued for its Kothur facility in Telangana
2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019 to be held in Mumbai
The theme for this year's conference, which will be held in Mumbai, is 'Securing your Supply Chain and Quality Management'